These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 7512709)

  • 1. The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids.
    Elliott K; Minami N; Kolesnikov YA; Pasternak GW; Inturrisi CE
    Pain; 1994 Jan; 56(1):69-75. PubMed ID: 7512709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor.
    Kolesnikov YA; Pick CG; Ciszewska G; Pasternak GW
    Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5162-6. PubMed ID: 7685116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-methyl-D-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug development.
    Elliott K; Kest B; Man A; Kao B; Inturrisi CE
    Neuropsychopharmacology; 1995 Dec; 13(4):347-56. PubMed ID: 8747759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The competitive alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to delta or kappa opioids.
    Kest B; McLemore G; Kao B; Inturrisi CE
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1249-55. PubMed ID: 9400000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro.
    Feng J; Kendig JJ
    Pain; 1996 Aug; 66(2-3):343-9. PubMed ID: 8880858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of mu and kappa 1 opioid analgesic tolerance by NPC17742, a novel NMDA antagonist.
    Kolesnikov YA; Ferkany J; Pasternak GW
    Life Sci; 1993; 53(19):1489-94. PubMed ID: 8412512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of nitric oxide in the development of morphine tolerance in rat hippocampal slices.
    Lue WM; Su MT; Lin WB; Tao PL
    Eur J Pharmacol; 1999 Oct; 383(2):129-35. PubMed ID: 10585526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the role of nitric oxide in kappa-opiate tolerance in mice.
    Thorat SN; Reddy PL; Bhargava HN
    Brain Res; 1993 Sep; 621(1):171-4. PubMed ID: 7693300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of nitric oxide in the development of opioid withdrawal induced by naloxone after acute treatment with mu- and kappa-opioid receptor agonists.
    Capasso A; Sorrentino L; Pinto A
    Eur J Pharmacol; 1998 Oct; 359(2-3):127-31. PubMed ID: 9832382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The comparison of effects of processed Aconiti tuber, U50488H and MK-801 on the antinociceptive tolerance to morphine.
    Shu H; Hayashida M; Huang W; An K; Chiba S; Hanaoka K; Arita H
    J Ethnopharmacol; 2008 Apr; 117(1):158-65. PubMed ID: 18328652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of morphine and enkephalin tolerance in 129/SvEv mice: evidence for a NMDA receptor defect.
    Kolesnikov Y; Jain S; Wilson R; Pasternak GW
    J Pharmacol Exp Ther; 1998 Feb; 284(2):455-9. PubMed ID: 9454784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological actions of a novel mixed opiate agonist/antagonist: naloxone benzoylhydrazone.
    Gistrak MA; Paul D; Hahn EF; Pasternak GW
    J Pharmacol Exp Ther; 1989 Nov; 251(2):469-76. PubMed ID: 2553921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dizocilpine (MK-801) on analgesia and tolerance induced by U-50,488H, a kappa-opioid receptor agonist, in the mouse.
    Bhargava HN; Thorat SN
    Brain Res; 1994 Jun; 649(1-2):111-6. PubMed ID: 7953621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY274614: assessment of opioid receptor changes.
    Tiseo PJ; Cheng J; Pasternak GW; Inturrisi CE
    J Pharmacol Exp Ther; 1994 Jan; 268(1):195-201. PubMed ID: 8301558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice.
    Bilsky EJ; Inturrisi CE; Sadée W; Hruby VJ; Porreca F
    Pain; 1996 Dec; 68(2-3):229-37. PubMed ID: 9121809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of nitric oxide/cyclic GMP in i.c.v. administered beta-endorphin- and (+)-cis-dioxolane-induced antinociception in the mouse.
    Xu JY; Tseng LF
    Eur J Pharmacol; 1994 Sep; 262(3):223-31. PubMed ID: 7813587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACEA-1328, an NMDA receptor antagonist, increases the potency of morphine and U50,488H in the tail flick test in mice.
    Lutfy K; Doan P; Nugyen M; Weber E
    Pharmacol Res; 1998 Dec; 38(6):453-60. PubMed ID: 9990654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The specific N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 blocks U-50,488, but not morphine antinociception.
    Kest B; Marek P; Liebeskind JC
    Brain Res; 1992 Aug; 589(1):139-42. PubMed ID: 1422813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide synthase inhibition blocks tolerance to the analgesic action of kappa-opiate receptor agonist in the rat.
    Bhargava HN
    Pharmacology; 1994 Apr; 48(4):234-41. PubMed ID: 7513892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of the development of morphine tolerance by U-50,488, an AVP antagonist or MK-801 in the rat hippocampal slice.
    Su MT; Lin WB; Lue WM; Cheng CY; Tao PL
    Br J Pharmacol; 1998 Feb; 123(4):625-30. PubMed ID: 9517380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.